Keep An Eye On ATNM Today, PETQ Upbeat, MTFB To Face FDA In Feb

Today's Daily Dose brings you news about Actinium's immediate catalyst; CEL-SCI Corp' progress in phase III Multikine study; PetIQ's upbeat outlook; Motif Bio's regulatory catalyst and ViewRay's stock offering.

from RTT - Biotech https://ift.tt/2MOg0T5
via IFTTT